Koser CU, Georghiou SB, Schon T, Salfinger M, et al. On the consequences of poorly defined breakpoints for rifampin susceptibility testing of Mycobacterium tuberculosis complex. J Clin Microbiol 2021 Feb 10. pii: JCM.02328-20. doi: 10.1128/JCM.02328.
PMID: 33568463